Synapse - Mutational signature analysis reveals patterns of genomic instability linked to resistance to endocrine therapy (ET) +/- CDK 4/6 inhibition (CDK4/6i) in estrogen receptor-positive/HER2-negative (ER+/HER2-) metastatic breast cancer (MBC)

Mutational signature analysis reveals patterns of genomic instability linked to resistance to endocrine therapy (ET) +/- CDK 4/6 inhibition (CDK4/6i) in estrogen receptor-positive/HER2-negative (ER+/HER2-) metastatic breast cancer (MBC) Meeting Abstract

Authors:	Marra, A.; Gazzo, A.; Gupta, A.; Selenica, P.; Da Silva, E. M.; Pareja, F.; Pei, X.; Zhu, Y.; Razavi, P.; Safonov, A.; Ferraro, E.; Harris, R.; Riaz, N.; Reis-Filho, J. S.; Chandarlapaty, S.
Abstract Title:	Mutational signature analysis reveals patterns of genomic instability linked to resistance to endocrine therapy (ET) +/- CDK 4/6 inhibition (CDK4/6i) in estrogen receptor-positive/HER2-negative (ER+/HER2-) metastatic breast cancer (MBC)
Meeting Title:	ESMO Congress 2022
Journal Title:	Annals of Oncology
Volume:	33
Issue:	Suppl. 7
Meeting Dates:	2022 Sep 9-13
Meeting Location:	Paris, France
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2022-09-01
Start Page:	S632
Language:	English
ACCESSION:	WOS:000866211600205
DOI:	10.1016/j.annonc.2022.07.249
PROVIDER:	wos
Notes:	Meeting Abstract: 210O -- Source: Wos